Alisha Norcross

CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3′-fluoro-4′-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a Bradykinin B1 Receptor Antagonist

B. Ma, M. Bock, S. Kuduk, 2008, Journal of Pharmacology and Experimental Therapeutics.

CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3 (cid:1) -fluoro-4 (cid:1) -{(1 R -biphenyl-2-carboxylate (MK-0686), a Bradykinin B 1 Receptor Antagonist

B. Ma, M. Bock, S. Kuduk, 2008 .

CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of MK-0686, a Bradykinin B1 Receptor Antagonist

B. Ma, M. Bock, S. Kuduk, 2008 .

Rhesus Monkeys of MK-0686, a Bradykinin B 1 Receptor Antagonist

B. Ma, M. Bock, S. Kuduk, 2008 .

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

P. Deutsch, J. Wagner, J. Stone, 2011, Journal of clinical pharmacology.

Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation

J. Lunceford, N. Hariparsad, J. Wagner, 2011, Journal of clinical pharmacology.